以老年肌少症、虚弱症及糖尿病为范例探讨中医“以证统病”实现共病管理的可行性  

Explore the possibiliy of multi-morbidity management with TCM theory,taking sarcopenia,frailty and diabetes as an example

作　　者：钟文[1,2] 谢春光[2] 高鸿[2] 刘桠[2] 晁俊[1] 方传明[2] 

机构地区：[1]成都中医药大学,四川成都611137 [2]成都中医药大学附属医院,四川成都610075

出　　处：《时珍国医国药》2017年第1期165-168,共4页Lishizhen Medicine and Materia Medica Research

基　　金：国家自然科学基金(No.81273749;No.81102589)

摘　　要：我国因逐步进入老龄化社会而面临巨大的挑战。老年人群往往多病共存、多重用药,共同导致不良预后。因此,共病管理成为老年疾病科研工作者的热门议题。西医思维模式预示其困境,而中医整体观念完全契合共病管理理念。本文以老年虚弱症、肌少症以及糖尿病为例,从中西医的角度分别论证其共同的病理环节,探讨"以证统病"进行共病管理的可能性。China is confronted with great challenge as stepping into the aging society. Geriatric population suffer from multi-morbidity and poly-pharmacy,which lead to poor prognosis. Therefore,multi-morbidity management become the hot topic among geriatric researchers. The western medical thinking pattern come across plight. However,holism concept of Chinese traditional medicine adapt well to the principle of multi-morbidity management. This article takes frailty,sarcopenia,as well as diabetes mellitus as examples,to explore the common pathophysiologic mechanism of the diseases,discuss the possibility of managing multi-morbidity with TCM theory—— ＂ top priority is syndrome,not disease＂.

关 键 词：老年疾病 虚弱症 糖尿病 肌少症 共病管理 多重用药 

分 类 号：R259[医药卫生—中西医结合]